In the News
Scrip Asks…What Does 2022 Hold For Biopharma? Part 5: Clinical Trials
Industry leaders sharing their predictions around clinical development homed in on decentralized trials, digitization and data tools as key topics for 2022…
12 Tech Trends To Watch Closely In 2022
For potentially life-saving drugs and treatments, the road to commercialization is steep. Virtualizing the clinical trial is listed as a tech trend to accelerate drugs discovery and development. As per CB Insights, “In silico techniques will cut the time and money it takes to develop a drug and insulate clinical trials from disruptions…
In Silico in Sight as Biopharma Game-Changer
Pharmaceutical Executive reporter discusses how a coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction. Read the full story here.
GNS Healthcare, MMRF Bring Patient Simulations to Multiple Myeloma Precision Treatment, Trial Design
Precision Oncology News reporter discusses Gemini and its prospective impact on multiple myeloma. Read more here.
GNS Healthcare Launches Computer Model of Disease Progression, Treatment Responses in Myeloma
Myeloma Research News covers GNS launch of Gemini. Read more here.
Wall Street Journal Covers GNS Launch of Gemini
This is the first AI-based virtual patient for multiple myeloma, said Colin Hill, the Cambridge, Mass.-based company’s co-founder and chief executive. It is traditionally difficult to predict how specific drugs or combinations of drugs might help individual multiple...
Cambia’s Peggy Maguire: Palliative Care Supports Economic Sustainability
Peggy Maguire, president of Cambia Health Foundation, shares how Cambia worked with GNS to use predictive analytics and identify members of Cambia's Medicare Advantage population that could benefit from an extra layer of support. Read the full article here.
WebMD discusses the impact of AI on healthcare
"The company Hill runs, GNS Healthcare, found a genetic signature in some multiple myeloma patients that suggested they would benefit from a transplant. For others, the risky, painful, and expensive procedure would probably only provide false hope." Read more here.
Study: If more Wisconsin doctors provided better care, key medical procedures would cost 30% less
The Milwaukee Journal Sentinel covers the results of a collaboration between the Wisconsin Business Group on Health and GNS Healthcare in identifying the impact of provider optimization on cost. Read the article!
Harvard Business Review: Using AI to Understand What Causes Diseases
Sema Sgaier and Francesca Domini of Surgo Foundation share how they causal AI can bring new clarity to understanding the underlying cause of disease. Read the full article here.